111 results
Page 4 of 6
8-K
EX-99.1
hcz0txpleo5r
18 Mar 21
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
8:31am
8-K
EX-99.1
arfcr j4th
5 Nov 20
Aeglea BioTherapeutics Reports Third Quarter 2020 Financial Results and Corporate Highlights
8:30am
8-K
EX-99.1
brw1opew
10 Aug 20
Aeglea BioTherapeutics Reports Second Quarter 2020 Financial Results and Corporate Highlights
8:30am
8-K
EX-99.1
o1bbxg 08
26 May 20
Regulation FD Disclosure
8:30am
8-K
EX-99.1
9ifx3mx6r veax7
7 May 20
Aeglea BioTherapeutics Reports First Quarter 2020 Financial Results and Corporate Highlights
8:30am
424B5
4a14dv6
28 Apr 20
Prospectus supplement for primary offering
4:10pm
424B5
u1box
27 Apr 20
Prospectus supplement for primary offering
4:09pm
8-K
251l196ls br34
16 Apr 20
Entry into a Material Definitive Agreement
8:49am
424B5
3g4b3qwd6gh34xkr f80
16 Apr 20
Prospectus supplement for primary offering
8:44am
8-K
920f blebxug
8 Apr 20
Other Events
7:30am
8-K
EX-99.1
ttrxs4i a9
24 Feb 20
Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones
7:30am
8-K/A
oot8j3s lb3h1
13 Jan 20
Regulation FD Disclosure
5:20pm